C. Fleming

662 total citations
21 papers, 505 citations indexed

About

C. Fleming is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, C. Fleming has authored 21 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in C. Fleming's work include Cystic Fibrosis Research Advances (9 papers), Pediatric health and respiratory diseases (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). C. Fleming is often cited by papers focused on Cystic Fibrosis Research Advances (9 papers), Pediatric health and respiratory diseases (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). C. Fleming collaborates with scholars based in Ireland, Australia and United Kingdom. C. Fleming's co-authors include Bruce K. Armstrong, Dallas R. English, Anne Kricker, Barry J. Plant, Desmond M. Murphy, Brien A. Holden, Fiona Stapleton, Deborah F. Sweeney, Mark Willcox and C. Shortt and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and CHEST Journal.

In The Last Decade

C. Fleming

18 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Fleming Ireland 8 163 151 107 94 88 21 505
Jennifer López United States 11 158 1.0× 115 0.8× 107 1.0× 167 1.8× 24 0.3× 23 536
Ying Zuo China 7 106 0.7× 160 1.1× 50 0.5× 88 0.9× 23 0.3× 12 418
Michael D. Zanolli United States 14 383 2.3× 59 0.4× 244 2.3× 36 0.4× 33 0.4× 28 757
E. Perea Spain 9 364 2.2× 37 0.2× 367 3.4× 209 2.2× 26 0.3× 15 633
Sibel Alper Türkiye 13 200 1.2× 28 0.2× 65 0.6× 30 0.3× 33 0.4× 38 452
Patti Stampone United States 10 251 1.5× 293 1.9× 332 3.1× 170 1.8× 10 0.1× 11 801
Stacie Bell United States 12 130 0.8× 28 0.2× 63 0.6× 49 0.5× 25 0.3× 35 598
Irshad Zaki United Kingdom 8 280 1.7× 94 0.6× 161 1.5× 48 0.5× 71 0.8× 10 507
Beverly Raasch Australia 12 451 2.8× 15 0.1× 450 4.2× 323 3.4× 29 0.3× 22 742
Zhifeng Huang China 14 56 0.3× 111 0.7× 47 0.4× 39 0.4× 19 0.2× 53 478

Countries citing papers authored by C. Fleming

Since Specialization
Citations

This map shows the geographic impact of C. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Fleming more than expected).

Fields of papers citing papers by C. Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Fleming. The network helps show where C. Fleming may publish in the future.

Co-authorship network of co-authors of C. Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of C. Fleming. A scholar is included among the top collaborators of C. Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Fleming. C. Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uddin, Md. Jashim, Mary K. Young, Girija Ramakrishnan, et al.. (2025). IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity. Journal of Clinical Investigation. 135(9). 2 indexed citations
2.
3.
Ibrahim, Hisham R., D. J. Morrissey, C. Fleming, et al.. (2023). Individualized approach to elexacaftor/tezacaftor/ivacaftor dosing in cystic fibrosis, in response to self-reported anxiety and neurocognitive adverse events: A case series. Frontiers in Pharmacology. 14. 1156621–1156621. 22 indexed citations
4.
McCarthy, Yvonne, C. Fleming, Mary B. Daly, et al.. (2023). ROCK STUDY in CF: sustained anti-inflammatory effects of lumacaftor–ivacaftor in sputum and peripheral blood samples of adult patients with cystic fibrosis—an observational study. BMJ Open Respiratory Research. 10(1). e001590–e001590. 3 indexed citations
5.
6.
Deane, Jennifer, Fiona Fouhy, N.J. Ronan, et al.. (2021). A multicentre analysis of Clostridium difficile in persons with Cystic Fibrosis demonstrates that carriage may be transient and highly variable with respect to strain and level. Journal of Infection. 82(3). 363–370. 3 indexed citations
7.
Shortt, C., et al.. (2019). IMPROVING PATIENT EDUCATION AND THE TRANSITION PROCESS USING VIRTUAL REALITY. eLearning and Software for Education. 1. 523–526.
8.
Fouhy, Fiona, N.J. Ronan, Órla O’Sullivan, et al.. (2017). A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis. Scientific Reports. 7(1). 6685–6685. 36 indexed citations
9.
Burke, Daniel, Michael J. Harrison, C. Fleming, et al.. (2016). Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection. Journal of Cystic Fibrosis. 16(2). 291–298. 25 indexed citations
10.
Ronan, N.J., Mary B. Daly, C. Fleming, et al.. (2016). Prevalence and perception of electronic cigarette (e-cigarette) use in an Irish cohort. PA2026–PA2026. 1 indexed citations
11.
Ronan, N.J., C. Fleming, Grace O’Callaghan, et al.. (2015). The Role of Ivacaftor in Severe Cystic Fibrosis in a Patient With the R117H Mutation. CHEST Journal. 148(3). e72–e75. 8 indexed citations
12.
Ronan, N.J., C. Shortt, C. Fleming, et al.. (2015). 128 The metabolic consequences of CFTR modulation with ivacaftor in a single adult cystic fibrosis centre cohort. Journal of Cystic Fibrosis. 14. S90–S90. 2 indexed citations
13.
Harrison, M.J., M. McCarthy, C. Fleming, et al.. (2014). Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF). Journal of Cystic Fibrosis. 13(6). 692–698. 49 indexed citations
14.
15.
Fleming, C., Chandrasekaran Kaliaperumal, & Michael Sullivan. (2011). Recurrent intramedullary epidermoid cyst of conus medullaris. BMJ Case Reports. 2011. bcr1120115090–bcr1120115090. 13 indexed citations
16.
English, Dallas R., Bruce K. Armstrong, Anne Kricker, & C. Fleming. (1997). Sunlight and cancer. Cancer Causes & Control. 8(3). 271–283. 260 indexed citations
17.
Stapleton, Fiona, et al.. (1995). Changes to the ocular biota with time in extended- and daily-wear disposable contact lens use. Infection and Immunity. 63(11). 4501–4505. 64 indexed citations
18.
Fleming, C., et al.. (1994). PRE-CORNEAL DEPOSITS DURING SOFT CONTACT LENS WEAR. Optometry and Vision Science. 71(Supplement). 152–153. 4 indexed citations
19.
Papas, Eric, et al.. (1994). HIGH DK SOFT CONTACT LENSES REDUCE THE LIMBAL VASCULAR RESPONSE. Optometry and Vision Science. 71(Supplement). 14–14. 3 indexed citations
20.
Fleming, C., et al.. (1987). Isolation of Mycoplasma pneumoniae from respiratory tract specimens in Ontario.. PubMed. 137(1). 48–50. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer López Breakdown of academic impact, for papers by Ying Zuo Breakdown of academic impact, for papers by Michael D. Zanolli Breakdown of academic impact, for papers by E. Perea Breakdown of academic impact, for papers by Sibel Alper Breakdown of academic impact, for papers by Patti Stampone Breakdown of academic impact, for papers by Stacie Bell Breakdown of academic impact, for papers by Irshad Zaki Breakdown of academic impact, for papers by Beverly Raasch Breakdown of academic impact, for papers by Zhifeng Huang
Rankless by CCL
2026